It said the Quad is working to identify and address vaccine gaps and barriers exacerbated by gender, disability and social inequities, and ensure safe, effective, affordable and quality-assured vaccination coverage in hard-to-reach areas.
Eligible children in the youngest cohort will get a second dose eight weeks after their first dose and can't receive any vaccination until four weeks after a positive test for coronavirus.
Although scientists say it is not yet necessary to tweak existing jabs, yet they warn of the emergence of a vaccine-evading variant. Thus, developing a global mechanism to make decisions about how and when to introduce these next generation jabs will be "critical".
The next phase of COVID-19 vaccination commenced from March 1 for people over 60 years and those aged 45 and above with specified co-morbid conditions. The country launched vaccination for all people aged more than 45 years from April 1.
During his two-day visit, Shringla will hold discussions with the State Administration Council headed by General Min Aung Hlaing, who seized power in February, political parties and members of civil society.
While Omicron was first reported in South Africa on November 24, India's first two cases of this heavily mutated version of the coronavirus were detected in Karnataka on December 2.
Covovax was assessed under the WHO EUL procedure based on the review of data on quality, safety and efficacy, a risk management plan, programmatic suitability, and manufacturing site inspections carried out by the Drugs Controller General of India.
The countrywide vaccination drive was rolled out on January 16 with healthcare workers (HCWs) getting inoculated in the first phase. The vaccination of frontline workers (FLWs) started from February 2.
Zydus Cadila's indigenously developed needle-free COVID-19 vaccine ZyCoV-D is set to become the first vaccine that will be available in India for those in the age group of 12-18 years. It has received Emergency Use Authorisation (EUA).
The vaccination drive has been ramped up through the availability of more vaccines, advanced visibility of vaccine availability to States and UTs for enabling better planning by them and streamlining the vaccine supply chain.
Seventy-three percent people in Odisha have developed antibodies against Covid-19. This information was given by director of RMRC (Regional Medical Research Centre), Sanghamitra Pati on Sunday (Sept 26).
Fenofibrate, which is approved for use by most countries in the world including the US Food and Drug Administration (FDA) and the UK's National Institute for Health and Care Excellence (NICE), is an oral drug currently used to treat conditions such as high levels of cholesterol and lipids (fatty substances) in the blood.
A day after Odisha government curtailed the mass vaccination programme in the State in the wake of acute shortage of doses, around 9.43 lakh jabs of Covishield vaccines manufactured by the Serum Institute of India reached the State on Friday.
The supply price of Covaxin to the government of India at Rs 150 a dose is a non-competitive price and clearly not sustainable in the long run. Hence a higher price in private markets is required to offset part of the costs, Bharat Biotech said on Tuesday.
Bhubaneswar: The Odisha government has decided to stop providing Covid-19 vaccines to private hospitalS from May 1 as the State is scheduled to launch vaccination for all above 18 years…
Panaji: Goa will offer free of cost vaccination to people above the age of 18 years, when the mass vaccination programme rolls out for all citizens of major age from…
New Delhi: A survey conducted by noted public health experts indicated that the side-effects post-vaccination, or ‘reactogenicity’ in medical linguistic, is likely to occur in 66 per cent of the healthcare workers which are most probably to subside within a day of their onset. The survey, which compiled the responses from 5,396 respondents, all healthcare […]
San Francisco: Facebook has announced to expand its efforts to remove false claims on its own platform and Instagram about Covid-19 and its vaccines. The expanded list of false Covid-19 and vaccine-related claims that will be removed include: Covid-19 is man-made; vaccines are not effective at preventing the disease they were created to protect against; […]
New Delhi: The government of India has put a big focus on healthcare in the Union Budget amid the coronavirus pandemic . Union Finance Minister Nirmala Sitharaman announced the ‘PM Aatmanirbhar Swastha Bharat’, to be launched with an outlay of Rs 64,180 crore over six years. A supplementary sum of Rs 35,000 crore has also […]
New Delhi: In a major shift of narrative, the government has now disapproved the authorisation of Bharat Biotech’s Covid vaccine to people below 18 years of age whereas earlier, it was approved for children above the age of 12 years by the Drugs Controller General of India (DCGI). A letter from the office of additional […]